UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2023 Earnings Call Transcript

UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2023 Earnings Call Transcript March 14, 2024

UroGen Pharma Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the UroGen Pharma Full Year 2023 Earnings Call. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Vincent Perrone,...